The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
Open accessAbstract
The immunosurveillance of transformed cells by the immune system remains one of the most controversial and poorly understood areas of immunity. Gene-targeted mice have greatly aided our understanding of the key effector molecules in tumor immunity. Herein, we describe spontaneous tumor development in gene-targeted mice lacking interferon (IFN)-γ and/or perforin (pfp), or the immunoregulatory cytokines, interleukin (IL)-12, IL-18, and tumor necrosis factor (TNF). Both IFN-γ and pfp were critical for suppression of lymphomagenesis, however the level of protection afforded by IFN-γ was strain specific. Lymphomas arising in IFN-γ-deficient mice were very nonimmunogenic compared with those derived from pfp-deficient mice, suggesting a comparatively weaker immunoselection pressure by IFN-γ. Single loss of IL-12, IL-18, or TNF was not sufficient for spontaneous tumor development. A significant incidence of late onset adenocarcinoma observed in both IFN-γ– and pfp-deficient mice indicated that some epithelial tissues were also subject to immunosurveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465 · cited 1×
“IFN- � ( 15 ) and perforin (pfp; references 5, 14, and 16), key molecules of both the innate and adaptive immune systems, contribute to tumor prevention in mice treated with the chemical carcinogen, methylcholanthrene (MCA), or in mice deficient for p53 expression.”
BackgroundPerforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Certain, S., Mathew, P. A., Henter, J.-I., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,241
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80543-9 · Cited by 911
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Self-citationTakeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775
Self-citationPerforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Self-citationPerforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Self-citationDecreased tumor surveillance in perforin-deficient mice.
van den Broek, M. E., Kägi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J., Zinkernagel, R. M., & Hengartner, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1781 · Cited by 512
Qin, Z., & Blankenstein, T. (2000) · Immunity · doi:10.1016/s1074-7613(00)80218-6 · Cited by 511
Regulation of Antigen-Specific CD8 + T Cell Homeostasis by Perforin and Interferon-γ
Badovinac, V. P., Tvinnereim, A. R., & Harty, J. T. (2000) · Science · doi:10.1126/science.290.5495.1354 · Cited by 438
Chu, C.-Q., Wittmer, S., & Dalton, D. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.123 · Cited by 418
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
Klenerman, P., & Zinkernagel, R. M. (1998) · Nature · doi:10.1038/28860 · Cited by 348
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
Self-citationPerforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Self-citationKörner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D., & Sedgwick, J. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1585 · Cited by 238
Interleukin-18, a proinflammatory cytokine.
Dinarello, C. A. (2000) · PubMed · Cited by 230
A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection
Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmire, J. K., Walsh, C. M., Clark, W. R., & Ahmed, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2527-2536.1999 · Cited by 221
Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080469697 · Cited by 201
Hayakawa, Y., Takeda, K., Yagita∥, H., Kakuta, S., Iwakura, Y., Kaer, L. V., Saiki, I., & Okumura, K. (2001) · PubMed · Cited by 184
Perforin dependence of natural killer cell‐mediated tumor control in vivo
van den Broek, M. F., Kägi, D., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251246 · Cited by 171
Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I., & Okumura, K. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1720::aid-immu1720>3.0.co;2-u · Cited by 161
Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
Kodama, T., Takeda, K., Shimozato, O., Hayakawa, Y., Atsuta, M., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (1999) · European Journal of Immunology · Cited by 155
Sinigaglia, F., D’Ambrosio, D., Panina‐Bordignon, P., & Rogge, L. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01329.x · Cited by 152
Smyth, M. J., Kelly, J. M., Baxter, A. G., Körner, H., & Sedgwick, J. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1611 · Cited by 148
Self-citationNakajima, C., Uekusa, Y., 岩崎, 正., Yamaguchi, N., Mukai, T., Gao, P. H., Tomura, M., Ono, S., Tsujimura, T., Fujiwara, H., et al. (2001) · Cancer Research · Cited by 122
Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity
Shustov, A. R., Luzina, I. G., Nguyen, P., Papadimitriou, J. C., Handwerger, B. S., Elkon, K. B., & Via, C. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8876 · Cited by 110
Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.
Gresser, I., Belardelli, F., Maury, C., Maunoury, M. T., & Tovey, M. G. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.158.6.2095 · Cited by 93
gamma-Interferon plays a key role in T-cell-induced tumor regression.
Tuttle, T. M., McCrady, C. W., Inge, T. H., Salour, M., & Bear, H. D. (1993) · PubMed · Cited by 64
Dobrzanski, M. J., Reome, J. B., & Dutton, R. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.424 · Cited by 47
Lymphocyte-mediated immunosurveillance of epithelial cancers?
Smyth, M. J., & Trapani, J. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01977-9 · Cited by 42
Self-citation
Cited by
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Self-citationCancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Metadata
- Authors
- Street, S. E. A., Trapani, J. A., MacGregor, D., & Smyth, M. J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-07-01
- Volume
- 196
- Issue
- 1
- Pages
- 129-134
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2149260641
- Cited by
- 375
- References
- 38
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.